Botulinum Neurotoxin Induces Neurotoxic Microglia Mediated by Exogenous Inflammatory Responses

Ghuncha Ambrin,You Jung Kang,Khanh Van Do,Charles Lee,Bal Ram Singh,Hansang Cho
DOI: https://doi.org/10.1002/advs.202305326
IF: 15.1
2024-02-13
Advanced Science
Abstract:Microfluidic based humanized mini brain model is utilized to investigate the intoxication with BoNT/A at the CNS, mimicking clinical dosage treatments. Thsese results identifies astrocytes as the key regulator of complement proteins responding to reduced acetylcholine with BoNT/A treatment. Initial neuroinflammation by reactive astrocytes inducing microgliosis. The exacerbated response of the proinflammatory microglia results in synaptic impairment, oxidative stress and neurodegeneration. Botulinum neurotoxin serotype A (BoNT/A) is widely used in therapeutics and cosmetics. The effects of multi‐dosed BoNT/A treatment are well documented on the peripheral nervous system (PNS), but much less is known on the central nervous system (CNS). Here, the mechanism of multi‐dosed BoNT/A leading to CNS neurodegeneration is explored by using the 3D human neuron‐glia model. BoNT/A treatment reduces acetylcholine, triggers astrocytic transforming growth factor beta, and upregulates C1q, C3, and C5 expression, inducing microglial proinflammation. The disintegration of the neuronal microtubules is escorted by microglial nitric oxide, interleukin 1β, tumor necrosis factor α, and interleukin 8. The microglial proinflammation eventually causes synaptic impairment, phosphorylated tau (pTau) aggregation, and the loss of the BoNT/A‐treated neurons. Taking a more holistic approach, the model will allow to assess therapeutics for the CNS neurodegeneration under the prolonged use of BoNT/A.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?